Board certification in endocrinology, obesity medicine, or family medicine is ideal but not required practical experience adjusting GLP-1 protocols based on patient-reported outcomes matters more than specialty designation alone
S2CID 10878355
The Judicial Panel on Multidistrict Litigation will hear arguments in Santa Barbara, CA, with respect to the application brought by plaintiffs to create a multidistrict litigation
Everybody would say, oh, its their own fault they can just eat a little bit less, thats all. So nobody would pay for it, nobody would support it, no government would help
GLP-1 medications such as semaglutide have shifted from diabetes-only treatments to recognized weight loss therapies for people across the metabolic spectrum
A study indicated that intronic single nucleotide polymorphism (SNPs) of NOD2 has been linked to PD risk (99)